Cite
Edwin TH, Henjum K, Nilsson LNG, et al. A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease. Alzheimers Dement (Amst). 2020;12(1):e12128doi: 10.1002/dad2.12128.
Edwin, T. H., Henjum, K., Nilsson, L. N. G., Watne, L. O., Persson, K., Eldholm, R. S., Saltvedt, I., Halaas, N. B., Selbæk, G., Engedal, K., Strand, B. H., & Knapskog, A. B. (2020). A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease. Alzheimer's & dementia (Amsterdam, Netherlands), 12(1), e12128. https://doi.org/10.1002/dad2.12128
Edwin, Trine Holt, et al. "A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 12,1 (2020): e12128. doi: https://doi.org/10.1002/dad2.12128
Edwin TH, Henjum K, Nilsson LNG, Watne LO, Persson K, Eldholm RS, Saltvedt I, Halaas NB, Selbæk G, Engedal K, Strand BH, Knapskog AB. A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease. Alzheimers Dement (Amst). 2020 Dec 07;12(1):e12128. doi: 10.1002/dad2.12128. eCollection 2020. PMID: 33313376; PMCID: PMC7720866.
Copy
Download .nbib